Nutrition

Moderna & Merck Announce 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in the Primary Endpoint of Recurrence-Free Survival in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection

Digital Pathology Market Growing at 9.9% CAGR to 2031 as AI Adoption Accelerates, says a 2026 Mordor Intelligence Report

HYDERABAD, India, Jan. 16, 2026 /PRNewswire/ -- According to Mordor Intelligence, the digital pathology market is valued at USD 2.01 billion in 2026, and is projected...

error: Content is protected !!